Crossmark

Rifaximin treatment in patients with severe alcohol-associated hepatitis: A multicenter, randomized controlled, open-label, pilot trial

Crossref DOI link: https://doi.org/10.1016/j.aohep.2024.101749

Published Print: 2025-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Song, Do Seon

Yang, Jin Mo

Jung, Young Kul

Yim, Hyung Joon

Kim, Hee Yeon

Kim, Chang Wook

Kim, Soon Sun

Cheong, Jae Youn https://orcid.org/0000-0001-6246-1783
Lee, Hae Lim

Lee, Sung Won https://orcid.org/0000-0002-5194-5130
Yoo, Jeong-Ju

Kim, Sang Gyune

Kim, Young Seok
License Information

Text and Data Mining valid from 2025-01-01

Text and Data Mining valid from 2025-01-01

Version of Record valid from 2024-11-26
More Information

This article is maintained by: Elsevier

Article Title: Rifaximin treatment in patients with severe alcohol-associated hepatitis: A multicenter, randomized controlled, open-label, pilot trial

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2024.101749

Content Type: article

Copyright: © 2024 Published by Elsevier España, S.L.U. on behalf of Fundación Clínica Médica Sur, A.C.